The Ronan Thompson Foundation and Solving Kids’ Cancer award $80,000 grant to fund new therapeutic antibody research to treat children with neuroblastoma and other ALK+ cancers.
The award of $80,000 was granted to the Children’s Hospital of Philadelphia (CHOP). Researchers believe that an ALK antibody will directly target the tumor cells and also help the immune system to attack the cancer, reducing the risk of a future recurrence. The plan is to use the ALK monoclonal antibody in combination with an ALK inhibitor to benefit more patients.
– See more at: http://www.theronanthompsonfoundation.com/about/funding#sthash.7gfSaKIS.dpuf